Jack Ronald Wall, PhD | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!

Jack Ronald Wall, PhD

University of Sydney
Nepean Clinical School
Nepean Hospital
Penrith, New South Wales, Australia

Jack Ronald Wall is a Professor of Medicine at University of Sydney (Nepean Clinical School). He heads the Discipline of Medicine and Department of Endocrinology at sci forschen. He became a full professor at McGill University in 1988. During all of this period he has carried out basic and clinical research into Graves’ disease, the associated ophthalmopathy, and related thyroid and orbital autoimmune disorders.

Professor Wall’s main area of research interest has been the eye muscle component of thyroid-associated ophthalmopathy for which he is known internationally. He was the first to focus on the autoimmune basis of ophthalmopathy and identify serum autoantibodies and to recognize the importance of the serum eye muscle antibodies as markers of eye muscle damage. He is the founding Medical Director of The International Thyroid Centre, and will develop new collaborative research studies with investigators in Fiji, PNG, the Philippines and Malaysia.

Professor Wall received his medical degree from University of Adelaide and PhD from London, UK.  He is a board member of the National Graves’ Disease Foundation and foundation scientific advisor, board member and co-founder of The Thyroid Foundation of Canada, the world’s first lay organization for diseases of the thyroid. The research interests of Professor Wall include thyroidology, bone disease, metabolic syndrome, pituitary medicine, general endocrinology, diabetes & metabolism,clinical immunology and internal medicine.


Representative Publications:

Thyroid-Stimulating Immunoglobulins as Measured in a Reporter Bioassay are not Detected in Patients With Hashimoto’s Thyroiditis and Ophthalmopathy or Isolated Upper Eyelid Retraction

Epitopes, Immunoglobulin Classes and Immunoglobulin G Subclasses of Calsequestrin Antibodies in Patients With Thyroid Eye Disease

Pathogenesis of Thyroid-Associated Ophthalmopathy: Does Autoimmunity Against Calsequestrin and Collagen XIII Play a Role?

Pretibial Myxoedema

Demonstration of the Production of the Long Acting Thyroid Stimulator (LATS) by Peripheral Lymphocytes Cultured in Vitro